Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of human age-dichotomized ER+, N0 breast tumors reveals enhanced NF kappa B and AP-1 activity associated with antiestrogen resistant breast caner

ABSTRACT: Signaling pathways that converge on two different transcription factor complexes, NFκB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen. In this study, biomarkers co-ordinately up-regulated by NFKB and AP-1 with prognositic significance are identified in a largely TAM-treated set of ER+ node negative breast cancers. The prognostic value with respect to age is also investigated. Experiment Overall Design: 54 ER+ node negative breast tumors with known clinical outcome were analyzed. Genes co-ordinately regulated by NFKB and AP1from literature are identified from a significant gene set obtained through a minimum variation filter. Biomarker expression is used to dichotomize samples into high vs. low expressors to determine prognostic value

ORGANISM(S): Homo sapiens

SUBMITTER: Christina Yau 

PROVIDER: E-GEOD-7378 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.

Zhou Yamei Y   Yau Christina C   Gray Joe W JW   Chew Karen K   Dairkee Shanaz H SH   Moore Dan H DH   Eppenberger Urs U   Eppenberger-Castori Serenella S   Benz Christopher C CC  

BMC cancer 20070403

<h4>Background</h4>Signaling pathways that converge on two different transcription factor complexes, NFkappaB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen.<h4>Methods</h4>Two cell line models of tamoxifen-resistant ER-positive breast cancer, MCF7/HER2 and BT474, showing increased AP-1 and NFkappaB DNA-binding and transcriptional activities, were studied to compare tamoxifen effects on NFkappaB and AP-1 regulated reporte  ...[more]

Similar Datasets

Unknown Expression data from age-dichotomized ER+, N0 breast tumors
2007-04-02 | GSE7378 | GEO
Transcriptomics microRNA expression profiling of early primary breast cancer to identify prognostic markers and associated pathways
2011-07-08 | E-GEOD-22216 | biostudies-arrayexpress
Transcriptomics Gene expression profiling of early primary breast cancer to identify prognostic markers and associated pathways
2011-07-08 | E-GEOD-22219 | biostudies-arrayexpress
Unknown The ets transcription factor ELF5 suppresses the estrogen sensitive phenotype and contributes to antiestrogen resistance in luminal breast cancer. [mouse]
2014-01-13 | GSE30406 | GEO
Unknown The ets transcription factor ELF5 suppresses the estrogen sensitive phenotype and contributes to antiestrogen resistance in luminal breast cancer. [human]
2012-12-27 | GSE30405 | GEO
Transcriptomics The ets transcription factor ELF5 suppresses the estrogen sensitive phenotype and contributes to antiestrogen resistance in luminal breast cancer. [mouse]
2014-01-13 | E-GEOD-30406 | biostudies-arrayexpress
Unknown Building Prognostic Models for Breast Cancer Patients Using Clinical Variables and Gene Expression Signatures
2010-10-25 | GSE15393 | GEO
Transcriptomics Building Prognostic Models for Breast Cancer Patients Using Clinical Variables and Gene Expression Signatures
2010-10-25 | E-GEOD-15393 | biostudies-arrayexpress
Unknown The ets transcription factor ELF5 suppresses the estrogen sensitive phenotype and contributes to antiestrogen resistance in luminal breast cancer. [human ChIP-Seq]
2012-12-27 | GSE31216 | GEO
Genomics The ets transcription factor ELF5 suppresses the estrogen sensitive phenotype and contributes to antiestrogen resistance in luminal breast cancer. [human ChIP-Seq]
2012-12-27 | E-GEOD-31216 | biostudies-arrayexpress